Learning Objectives:
- Kevin Knopf, MD, VIVIO Director of Clinical Innovation is on this panel on the current state of affairs for the global and US oncology biosimilar market.
- Identify existing and/or anticipated barriers to adoption of biosimilars from various stakeholders
(payor, provider, c-suite, community) - Discuss strategies and best practice solutions to help optimize biosimilar adoption
- Describe current and future policies or regulations impacting biosimilar ecosystem
Strategies for Overcoming Existing or Anticipated Barriers
Panel Discussion:
• Academic Health System Perspective
• Community Cancer Center Perspective
• Payer Perspective
Panelists: Kevin Knopf, MD, Kathy Oubre, MS, Desiree Otenti, MNS
